TNGX - Tango Therapeutics GAAP EPS of -$0.28 beats by $0.03 revenue of $5.78M beats by $0.12M August, 10 2022 08:09 AM Tango Therapeutics Inc. Tango Therapeutics press release ( NASDAQ: TNGX ): Q2 GAAP EPS of -$0.28 beats by $0.03 . Revenue of $5.78M (-68.2% Y/Y) beats by $0.12M . For further details see: Tango Therapeutics GAAP EPS of -$0.28 beats by $0.03, revenue of $5.78M beats by $0.12M